Anubis Barcelona
NDC 83021-839, Propanediol, Glycerin, Magnesium Ascorbyl Phosphate, concentrate, from ANUBIS COSMETICS SL.
- Product NDC
- 83021-839
- Status
- Listed
- Labeler
- ANUBIS COSMETICS SL
- Dosage form
- CONCENTRATE
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- M016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83021-839 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCERIN.01035 g/1.5mL
- PHENOXYETHANOL.0003 g/1.5mL
- FRAGRANCE 13576.00285 g/1.5mL
- DEHYDROACETIC ACID.00135 g/1.5mL
- WATER1.16659425 mL/1.5mL
- PEG-8 CAPRYLIC/CAPRIC GLYCERIDES.15 g/1.5mL
- ISOMETHYL-.ALPHA.-IONONE.00003 g/1.5mL
- EDETIC ACID.000009 g/1.5mL
- BENZOIC ACID.0009 g/1.5mL
- SORBIC ACID.0006 g/1.5mL
- BENZYL ALCOHOL.01215 g/1.5mL
- PROPANEDIOL.15 g/1.5mL
- HYDROXYCITRONELLAL.00006 g/1.5mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Decreased Coagulation Factor Activity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Lead Chelating Activity [MoA]; Lead Chelator [EPC]; Nitrogen Binding Agent [EPC]; Non-Standardized Chemical Allergen [EPC]; Pediculicide [EPC]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83021-839-07 | 83021083907 | 1.5 mL in 1 VIAL, SINGLE-USE (83021-839-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83021-839 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83021-839 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83021-839. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.